Acclarent Raises $35 Million

Acclarent Inc., a Menlo Park, Calif.-based developer of surgical devices for treating ear, nose and throat ailments, has raised around $35 million in Series C funding, according to a regulatory filing. Meritech Capital Partners led the deal, and was joined by Delphi Ventures, New Enterprise Associates and Versant Ventures.